蓝光滤过型人工晶状体对白内障术后失眠的影响:一项随访10年的全国性队列研究
该全国性队列研究纳入2008至2013年双眼白内障手术患者171,415例,比较蓝光滤过型人工晶状体(BF-IOL)与非BF-IOL组临床诊断失眠的发生率,平均随访6.2年。BF-IOL组失眠发生率为2.97/100人年,非BF-IOL组为3.21/100人年;竞争风险模型SHR 0.98(95%CI 0.95-1.01),倾向性评分匹配后HR 0.97(95%CI 0.92-1.01),两组无显著差异。结论认为在台湾使用BF-IOL长达10年就失眠而言未见明显劣势。
要点
- BF-IOL组失眠发生率为2.97/100人年,非BF-IOL组为3.21/100人年。
- 竞争风险模型SHR 0.98(95%CI 0.95-1.01),匹配后HR 0.97(95%CI 0.92-1.01)。
- 各年龄、性别及有无良性前列腺增生男性亚组中两组失眠率均无显著差异。
核心结论
- 在台湾,使用BF-IOL长达10年就失眠而言未见明显劣于非BF-IOL。
研究设计与样本
- 全国性队列研究,使用台湾全民健康保险研究数据库。
- 纳入2008至2013年间双眼白内障手术患者171,415例,随访至2018年。
- 采用倾向性评分匹配平衡两组基线特征,使用Cox模型和病因特异性风险模型估计HR和SHR。
主要发现
- BF-IOL组19,604例(11.4%),非BF-IOL组151,811例(88.6%)。
- BF-IOL组倾向更年轻且慢性病更少。
- 平均随访6.2年,BF-IOL组失眠发生率为2.97/100人年,非BF-IOL组为3.21/100人年。
- 以全因死亡为竞争风险,SHR 0.98(95%CI 0.95-1.01);倾向性评分匹配后HR 0.97(95%CI 0.92-1.01),均无显著差异。
- 亚组分析显示各年龄组、两性别组及有无良性前列腺增生的男性中,两组失眠率均无显著差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To compare the incidence of clinically diagnosed insomnia after cataract surgery in pseudophakic eyes with blue light-filtering intraocular lenses (BF-IOLs) and non-BF-IOLs. DESIGN: Nationwide cohort study using the Taiwan National Health Insurance Research Database. METHODS: We enrolled 171,415 patients who underwent cataract surgery in both eyes between 2008 and 2013 and followed them till 2018. Propensity score matching (PSM) was used to balance the baseline characteristics between the 2 IOL groups. The Cox model and cause-specific hazard model were used to estimate the hazard ratios (HRs) and subdistribution hazard ratio (SHR). RESULTS: Overall, 19,604 (11.4%) and 151,811 (88.6%) patients had BF-IOL and non-BF-IOL implants, respectively. The BF-IOL group tended to be younger and had fewer chronic diseases. Within a mean follow-up period of 6.2 years, the incidence rates of insomnia (per 100 person-years) in the BF-IOL and non-BF-IOL groups were 2.97 and 3.21, respectively. There was no significant difference in the incidence rate of insomnia between the 2 IOL groups after treating all-cause mortality as a competing risk (SHR 0.98, 95% CI 0.95-1.01) and after PSM (HR 0.97, 95% CI 0.92-1.01), respectively. Subgroup analysis revealed no significant difference in the insomnia rate between the 2 IOL groups for various age groups, 2 sex groups, and men with and without benign prostatic hyperplasia. CONCLUSION: In Taiwan, the use of a BF-IOL for up to 10 years had no apparent disadvantage over non-BF-IOLs with respect to insomnia.
引用
- See LC, Li PR, Lin KK, et al. Effect of Blue Light-Filtering Intraocular Lenses on Insomnia After Cataract Surgery: A Nationwide Cohort Study With 10-Year Follow-up. Am J Ophthalmol. 2022. PMID: 35123954. doi:10.1016/j.ajo.2022.01.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。